Brussels: The European Union could pay more than $10 billion to secure hundreds of millions of doses of the vaccine candidates being developed by Pfizer-BioNTech and CureVac, an EU official involved in the talks told Reuters. The bloc has agreed to pay 15.50 euros ($18.34) per dose for the Covid-19 vaccine candidate being developed by Pfizer and BioNTech, according to the official. That would mean an overall price of up to 3.1 billion euros ($3.7 billion) for 200 million doses, rising to 4.65 billion euros if another optional 100 million doses are purchased under the deal, the official said....
Full ArticleEU could pay over $10 billion for Pfizer and CureVac vaccines
WorldNews
0 shares
1 views
You might like
Related news coverage
Nvidia & darpa biohybrid
Rumble
https://www.youtube.com/watch?v=0Hg7XhbXuac . No One is Talking About What Just Happened..
Advertisement
More coverage
The Latest: Philippines targets 60 million for vaccination
SeattlePI.com
MANILA, Philippines — Philippine officials say about 60 million Filipinos are being targeted for vaccination against the..
-
News24.com | WATCH | EU could pay $10 billion for vaccines - source
News24
-
Pfizer, Moderna COVID-19 vaccine candidates may get EU approval in December
Proactive Investors
-
Operation Warp Speed bought 100 million doses of Pfizer's and Moderna's vaccines before results came in. That $3.5 billion bet is paying off.
Business Insider
-
African continent hits 2 million confirmed coronavirus cases
SeattlePI.com